-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Opiant Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2021.
- Opiant Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$9.92M, a 390% decline year-over-year.
- Opiant Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$33.1M, a 2206% decline year-over-year.
- Opiant Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $3.01M.
- Opiant Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$1.86M, a 116% decline from 2019.
- Opiant Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was $11.6M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)